Cite

HARVARD Citation

    Maruyama, D. et al. (2017). Phase I/II study of pralatrexate in Japanese patients with relapsed or refractory peripheral T‐cell lymphoma. Cancer science. 108 (10), pp. 2061-2068. [Online]. 
  
Back to record